Black Swift Group’s Pfizer PFE Stock Holding History

Black Swift Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-111,750	Closed	-$2.85M	–	131
2025 Q3	$2.85M	Buy	+111,750	New	+$2.76M	0.5%	45
2024 Q1	–	Sell	-10,000	Closed	-$288K	–	116
2023 Q4	$288K	Buy	+10,000	New	+$302K	0.09%	77

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Black Swift Group's PFE Position: Q4 2025 in Review

Black Swift Group sold out of Pfizer (PFE) in Q4 2025, closing a stake of 111,750 shares — an estimated $2.85M sold.

Black Swift Group first reported a position in PFE in Q4 2023 and held it in 2 quarters. The position peaked at $2.85M in Q3 2025. 2,906 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

Black Swift Group reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
Black Swift Group sold 111,750 Pfizer shares in Q4 2025, an estimated $2.85M.
Black Swift Group first reported a position in Pfizer in Q4 2023 and held it in 2 quarters.
Black Swift Group's Pfizer position peaked at $2.85M in Q3 2025.
2,906 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Black Swift Group's 13F filing for Q4 2025, filed 10 Feb 2026.